Truncating SRCAP variants outside the Floating-Harbor syndrome locus cause a distinct neurodevelopmental disorder with a specific DNA methylation signature

Am J Hum Genet. 2021 Jun 3;108(6):1053-1068. doi: 10.1016/j.ajhg.2021.04.008. Epub 2021 Apr 27.

Abstract

Truncating variants in exons 33 and 34 of the SNF2-related CREBBP activator protein (SRCAP) gene cause the neurodevelopmental disorder (NDD) Floating-Harbor syndrome (FLHS), characterized by short stature, speech delay, and facial dysmorphism. Here, we present a cohort of 33 individuals with clinical features distinct from FLHS and truncating (mostly de novo) SRCAP variants either proximal (n = 28) or distal (n = 5) to the FLHS locus. Detailed clinical characterization of the proximal SRCAP individuals identified shared characteristics: developmental delay with or without intellectual disability, behavioral and psychiatric problems, non-specific facial features, musculoskeletal issues, and hypotonia. Because FLHS is known to be associated with a unique set of DNA methylation (DNAm) changes in blood, a DNAm signature, we investigated whether there was a distinct signature associated with our affected individuals. A machine-learning model, based on the FLHS DNAm signature, negatively classified all our tested subjects. Comparing proximal variants with typically developing controls, we identified a DNAm signature distinct from the FLHS signature. Based on the DNAm and clinical data, we refer to the condition as "non-FLHS SRCAP-related NDD." All five distal variants classified negatively using the FLHS DNAm model while two classified positively using the proximal model. This suggests divergent pathogenicity of these variants, though clinically the distal group presented with NDD, similar to the proximal SRCAP group. In summary, for SRCAP, there is a clear relationship between variant location, DNAm profile, and clinical phenotype. These results highlight the power of combined epigenetic, molecular, and clinical studies to identify and characterize genotype-epigenotype-phenotype correlations.

Keywords: DNA methylation signature; Floating-Harbor syndrome; SRCAP; epigenomics; genotype-phenotype correlation; intellectual disability; neurodevelopmental disorders; non-FLHS SRCAP-related NDD; nonsense-mediated decay; speech delay.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abnormalities, Multiple / genetics
  • Abnormalities, Multiple / pathology*
  • Adenosine Triphosphatases / genetics*
  • Case-Control Studies
  • Cohort Studies
  • Craniofacial Abnormalities / genetics
  • Craniofacial Abnormalities / pathology*
  • DNA Methylation*
  • Epigenesis, Genetic*
  • Female
  • Genetic Predisposition to Disease
  • Growth Disorders / genetics
  • Growth Disorders / pathology*
  • Heart Septal Defects, Ventricular / genetics
  • Heart Septal Defects, Ventricular / pathology*
  • Humans
  • Infant, Newborn
  • Male
  • Mutation*
  • Neurodevelopmental Disorders / genetics
  • Neurodevelopmental Disorders / pathology*
  • Phenotype*

Substances

  • Adenosine Triphosphatases
  • SRCAP protein, human

Supplementary concepts

  • Floating-harbor syndrome